Androgen deprivation therapy for prostate cancer and cardiovascular death

JAMA

Volumn 307, Issue 12, 2012, Pages 1252-

  Blankfield, Robert P ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN DEPRIVATION THERAPY; DATA COLLECTION METHOD; DISEASE ASSOCIATION; HEART DEATH; HUMAN; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; SAMPLING ERROR; TREATMENT DURATION; VALIDITY; CARDIOVASCULAR DISEASE; MALE; MORTALITY; NOTE; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTIANDROGEN;

ANDROGEN ANTAGONISTS; CARDIOVASCULAR DISEASES; HUMANS; MALE; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84859181211     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.352     Document Type: Letter

References (5)

1. Nguyen PL, Je Y, Schutz FA, et al. Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. JAMA. 2011;306(21):2359-2366.
2. Messing EM, Manola J, Yao J, et al; Eastern Cooperative Oncology Group study EST 3886. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol. 2006;7(6):472-479. (Pubitemid 43779173)
3. Schröder FH, Kurth K-H, Fossa SD, et al. Early versus delayed endocrine treatment of T2-T3 pN1-3 M0 prostate cancer without local treatment of the primary tumour: final results of European Organisation for the Research and Treatment of Cancer protocol 30846 after 13 years of follow-up (a randomised controlled trial). Eur Urol. 2009;55(1):14-22.
4. Studer UE, Whelan P, Albrecht W, et al. Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891. J Clin Oncol. 2006;24(12):1868-1876. (Pubitemid 46638985)
5. Efstathiou JA, Bae K, Shipley WU, et al. Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31. J Clin Oncol. 2009;27(1):92-99.